Omkar Speciality Chemicals Ltd - 533317 - Board Meeting Intimation for Intimation Of Meeting Of Board Of Directors To Be Held On June 12, 2026
Omkar Speciality Chemicals board will meet on June 12, 2026. The agenda includes considering and approving audited financial statements for the quarter and financial year ended March 31, 2026, and changing the registered office address.
Jun 09 2026 22:51:39
Omkar Speciality Chemicals Ltd - 533317 -
Appointment Of Secretarial Auditor Of The Company.
Omkar Speciality's Monitoring Committee approved unaudited financial results for Q1, Q2, and Q3 FY26. Key appointments, including a new CEO, Independent Director, and Statutory Auditors, were also made as the company progresses post-NCLT resolution plan approval.
May 28 2026 23:39:55
Omkar Speciality Chemicals Ltd - 533317 - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
Omkar Specialty Chemicals appointed M/s. R. R. Tibrewala & Co. as its Statutory Auditors for FY2025-26. This appointment fills a casual vacancy and formalizes the company's governance structure post-CIRP.
May 28 2026 23:35:23
Omkar Speciality Chemicals Ltd - 533317 - Announcement under Regulation 30 (LODR)-Change in Management
Omkar Speciality Chemicals announced the appointment of Mr. Dipak Kumar Shaw as its Chief Executive Officer (CEO), effective May 27, 2026. This appointment is a key leadership change following the approval of the company's Corporate Insolvency Resolution Process (CIRP) plan.
May 28 2026 23:30:07
Omkar Speciality Chemicals Ltd - 533317 - Announcement under Regulation 30 (LODR)-Change in Management
Omkar Speciality Chemicals announced the appointment of Mr. Dipak Kumar Shaw as its Chief Executive Officer (CEO), effective May 27, 2026. This appointment is a key leadership change following the approval of the company's Corporate Insolvency Resolution Process (CIRP) plan.
May 28 2026 23:26:48
Omkar Speciality Chemicals Ltd - 533317 - Board Meeting Outcome for Outcome Of The Meeting Of Monitoring Committee Of Omkar Speciality Chemicals Limited ('The Company') Held On Wednesday, May 27, 2026
Omkar Speciality Chemicals' monitoring committee approved financial results for Q1, Q2, and Q3 FY26, reporting a Q3 net loss of ₹32.84 lakhs and zero operational revenue. Key appointments were also approved, including Mr. Dipak Kumar Shaw as CEO.
May 28 2026 23:02:15
Omkar Speciality Chemicals Ltd - 533317 - Board Meeting Intimation for Intimation Of The Meeting Of The Monitoring Committee To Be Held On May 27, 2026
Omkar Speciality Chemicals' Monitoring Committee will convene on May 27, 2026, to review and approve the unaudited financial results for Q1, Q2, and Q3 FY26. The agenda also includes the appointment of a new CEO, an Independent Director, and Statutory Auditors to fill a casual vacancy, alongside discussions on CIRP costs.
May 22 2026 21:37:16
Read More